基本资料 投资组合 财务数据 基金公告
创金合信全球医药生物股票发起(QDII)C(018156) |
净值：
1.5963
|
日增长率：
-2.34%
|
累计净值：1.5963 | 2026-02-05 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| EWTX | Edgewise Therapeutics Inc | 238,619.00 | 41,619,847.71 | 5.04 |
| TSHA | Taysha Gene Therapies Inc | 883,099.00 | 34,139,194.38 | 4.14 |
| ANAB | AnaptysBio Inc | 94,850.00 | 32,320,727.85 | 3.92 |
| OLMA | Olema Pharmaceuticals Inc | 160,006.00 | 28,116,254.32 | 3.41 |
| URGN | 乌龙制药 | 167,595.00 | 27,588,566.46 | 3.34 |
| AQST | Aquestive Therapeutics Inc | 520,306.00 | 23,625,039.21 | 2.86 |
| GRAL | GRAIL Inc | 38,381.00 | 23,089,817.39 | 2.80 |
| RYTM | Rhythm Pharmaceuticals Inc | 30,306.00 | 22,801,105.56 | 2.76 |
| EBS | Emergent BioSolutions Inc | 259,300.00 | 22,526,938.50 | 2.73 |
| NKTR | 内克塔治疗 | 74,348.00 | 22,094,564.96 | 2.68 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2025-12-31 | 89.93 | - | 20.40 | 825,065,395.56 |
| 2025-09-30 | 85.79 | - | 13.08 | 39,332,950.53 |
| 2025-06-30 | 84.55 | - | 9.62 | 13,846,914.86 |
| 2025-03-31 | 84.53 | - | 18.85 | 12,369,113.13 |
| 2024-12-31 | 81.01 | - | 15.98 | 12,618,309.46 |
微信公众号
证券之星APP
